Showing results (1-10 of 537) with videos related to

Sort By:
Pageof 54
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|November 23, 2007
Use of interleukin-2 in the management of haematological malignancies: focus on minimal residual diseaseF Mandelli, S Capria, M Vignetti, et al.
Haematologica|August 27, 1998
Chronic lymphocytic leukemia: from palliative therapy to curative intentG Meloni, F R Mauro, A Proia, et al.
Blood|June 15, 1990
BAVC regimen and autologous bone marrow transplantation in patients with acute myelogenous leukemia in second remissionG Meloni, P De Fabritiis, M C Petti, et al.
Leukemia|November 1, 1992
Has IL2 a role in the management of minimal residual disease for acute leukemia?R Foa, G Meloni, A Guarini, et al.
Stem Cells (Dayton, Ohio)|July 1, 1993
Interleukin 2 treatment in acute myelogenous leukemiaF Mandelli, M Vignetti, S Tosti, et al.
Haematologica|November 1, 1990
IL-2 in the treatment of chronic myeloid leukemia after lymphoid blast crisis: a pilot studyG Meloni, R Foà, S Tosti, et al.
Leukemia & Lymphoma|May 1, 1996
Interleukin-2 for the treatment of advanced acute myelogenous leukemia patients with limited disease: updated experience with 20 casesG Meloni, M Vignetti, C Andrizzi, et al.
Haematologica|September 1, 1994
Pure red cell aplasia following peripheral stem cell transplantation: complete response to a short course of high-dose recombinant human erythropoietinM Martelli, L Ponchio, Y Beguin, et al.
Leukemia|February 1, 1989
Phase II trial of intermediate dose ARA-C (IDAC) with sequential mitoxantrone (MITOX) in acute myelogenous leukemiaS Amadori, G Meloni, M C Petti, et al.
European Journal of Haematology|May 1, 1989
Acute myelogenous leukemia in first relapse treated with two consecutive autologous bone marrow transplantations: a pilot studyG Meloni, P De Fabritis, A Pulsoni, et al.
Pageof 54